Screening colorectal cancer associated autoantigens through multi-omics analysis and diagnostic performance evaluation of corresponding autoantibodies
A five biomarker panel can server as complementary biomarker to CEA and CA19-9 in CRC detection.
Authors
- Yifan Cheng (ORCID: https://orcid.org/0000-0003-0274-0611)
- Liping Dai
- Donglin Jiang (ORCID: https://orcid.org/0000-0001-6199-4385)
- Lei Peng (ORCID: https://orcid.org/0000-0003-2932-8504)
- Zhongmin Qiu (ORCID: https://orcid.org/0000-0002-6612-7413)
- Hua Ye
- Jianxiang Shi (ORCID: https://orcid.org/0000-0002-4346-3895)
- Xinwei Wang (ORCID: https://orcid.org/0009-0000-4823-6977)
- Peng Wang (ORCID: https://orcid.org/0000-0002-2972-7495)
- Xiaoyue Zhang (ORCID: https://orcid.org/0009-0006-7038-8583)
- Lu Yin (ORCID: https://orcid.org/0000-0001-9707-4011)
- Tao Li (ORCID: https://orcid.org/0000-0002-5108-1774)
- Haiyan Liu (ORCID: https://orcid.org/0000-0002-4961-4252)
- Keyan Wang (ORCID: https://orcid.org/0000-0002-7241-1656)
- Yinan Jiang (ORCID: https://orcid.org/0000-0002-3602-7278)
- Zhijun Kang (ORCID: https://orcid.org/0009-0003-4234-6659)
Institutions
- Zhengzhou University (CN)
- Zhengzhou Business University (CN)
Publication Details
- Journal
- BMC Cancer
- Published
- 2025-04-16
- DOI
- https://doi.org/10.1186/s12885-025-14080-5
- Citations
- 4
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 4.18
Funders
- Zhengzhou University